Market Highlights
The Poultry Vaccines Market Share was worth USD 1.8 billion in 2022
and is expected to reach USD 3.32 billion by 2032 at 7.05% CAGR during the
forecast period 2023 to 2032.
The high
cost associated with poultry vaccines, lack of awareness regarding poultry
vaccines, and unaffordability of veterinary services in underdeveloped and
developing regions may hamper the growth of the Poultry Vaccines Market
Share during the assessment period. For instance, according to the National
Institute of Standards and Technology (NIST), in January 2016, more than 35.0%
of vaccines lost their potency during the global shipping, as they were stored
at temperatures that were either too high or too low.
Segmentation
The global Poultry Vaccines Market Outlook has been segmented based on diseases, technology, dosage form and region.
· Based on disease, the market has been classified as infectious bronchitis, avian influenza, marek's disease, newcastle disease, and others. the market, by technology, has been segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines, live attenuated vaccines (lav), and others. based on dosage form, the market has been segmented into duct vaccines, liquid vaccines, and freeze-dried vaccines.
· Based on technology, live attenuated vaccines segment is expected to hold the largest market share of the poultry vaccines market during the forecast period. Also, recombinant vaccines segment to register the fastest growth in the global poultry vaccines market during the forecast period.
Key
Players
Some of the
key Poultry Vaccines Market Players are
Boehringer
Ingelheim,
Elanco,
MSD &
Co.,
Zoetis Inc,
Ceva Animal
Health Inc.,
Phibro
Animal Health Corporation,
Virbac,
Hipra,
Venkys,
Biovet, and
Anicon GmbH,
and
Others.
Regional Analysis
The Poultry
Vaccines Market Outlook is likely to dominate by Americas during the forecast
period owing to the awareness about the prevention of animal-to-human
transmission diseases, rising demand for safe animal food supply, and
increasing investment in research and development for animal vaccines. Moreover, high expenditure spending
and favorable reimbursement policy also fueling the growth of the market during
forecast periods. The European market is expected to be the second-largest due
to government support for research & development and improved animal
husbandry practices. However, the market in Asia-Pacific is anticipated to be
the fastest-growing during the forecast period owing to rising awareness and
increase in the number of animal welfare programs. The market in the Middle
East & Africa is likely to account for the smallest share of the global
poultry vaccines market.
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York
10013
